Compare TSAT & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSAT | LUNG |
|---|---|---|
| Founded | 1969 | 1995 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.8M | 63.6M |
| IPO Year | 1996 | 2020 |
| Metric | TSAT | LUNG |
|---|---|---|
| Price | $27.41 | $2.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $6.81 |
| AVG Volume (30 Days) | 114.8K | ★ 1.0M |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $324,440,552.00 | $91,664,000.00 |
| Revenue This Year | N/A | $9.21 |
| Revenue Next Year | N/A | $5.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 15.59 |
| 52 Week Low | $14.31 | $1.31 |
| 52 Week High | $36.85 | $9.37 |
| Indicator | TSAT | LUNG |
|---|---|---|
| Relative Strength Index (RSI) | 47.00 | 69.54 |
| Support Level | $26.83 | $2.43 |
| Resistance Level | $36.77 | $2.66 |
| Average True Range (ATR) | 2.37 | 0.20 |
| MACD | -0.08 | 0.06 |
| Stochastic Oscillator | 22.44 | 90.37 |
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.